Skip to main content
Clinical Trials/IRCT2015091624054N1
IRCT2015091624054N1
Completed
未知

The Effectiveness of Group Metacognitive Therapy on DefenseMechanisms, Resiliency and Self Efficacy of Females with MultipleSclerosis

Investigator0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Investigator
Enrollment
30
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Investigator

Eligibility Criteria

Inclusion Criteria

  • Main inclusion and exclusion criteria:
  • The final diagnosis of developing MS by the neurologist, signing a written consent form to participate in the study, having at least a diploma and achieving scores 1 to 4 in EDSS diagnosed by the neurologist.
  • Exclusion criteria: Receiving psychological treatments at least six month prior to entering the study, a history of metabolic diseases like thyroid and absence of more than two sessions.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials